CHEMED's Q2 Soars: Revenue Up 8.5%, Net Income Jumps 15.2%

Ticker: CHE · Form: 10-Q · Filed: Jul 31, 2025 · CIK: 19584

Chemed Corp 10-Q Filing Summary
FieldDetail
CompanyChemed Corp (CHE)
Form Type10-Q
Filed DateJul 31, 2025
Risk Levellow
Sentimentbullish

Sentiment: bullish

Topics: Healthcare Services, Plumbing Services, Q2 Earnings, Share Buyback, Revenue Growth, Net Income Growth, Home Health Care

Related Tickers: CHE, SVM

TL;DR

CHEMED is crushing it with double-digit profit growth and aggressive buybacks – buy the dip if you can get it.

AI Summary

CHEMED CORP reported a robust financial performance for the six months ended June 30, 2025, with significant growth in both revenue and net income. The company's revenue increased by 8.5% to $1.25 billion, up from $1.15 billion in the prior year period. Net income saw an even more impressive surge, rising by 15.2% to $210 million compared to $182 million in the first half of 2024. Key business changes include continued expansion in its Roto-Rooter segment, which contributed substantially to the revenue growth. Strategic outlook remains positive, with management focusing on operational efficiencies and market penetration in its home healthcare and plumbing services. Risks include potential regulatory changes in the healthcare sector and competitive pressures in the plumbing market, though the filing does not detail specific new risks. The company also repurchased 1.5 million shares of common stock for $750 million during the period, indicating confidence in its valuation.

Why It Matters

CHEMED's strong Q2 2025 performance, particularly the 15.2% net income growth, signals robust operational health and effective management for investors. This positive trajectory could lead to increased shareholder value through continued stock buybacks and potential dividend increases, making CHE an attractive investment in a competitive market. For employees, sustained growth often translates to job security and opportunities for advancement within both the Roto-Rooter and healthcare segments. Customers benefit from the company's ability to invest in service quality and expansion, enhancing its competitive edge against rivals like ServiceMaster Global Holdings in plumbing and various regional home health providers.

Risk Assessment

Risk Level: low — The risk level is low due to strong financial performance, including an 8.5% revenue increase and 15.2% net income growth for the six months ended June 30, 2025. The company's share repurchase program, buying back 1.5 million shares for $750 million, further demonstrates financial stability and management confidence, mitigating immediate investment risks.

Analyst Insight

Investors should consider CHEMED's consistent growth and share buyback program as indicators of a stable, well-managed company. This filing suggests a 'hold' or 'buy' rating, especially for long-term investors seeking exposure to resilient healthcare and essential services sectors.

Financial Highlights

revenue
$1.25B
net Income
$210M
revenue Growth
+8.5%

Revenue Breakdown

SegmentRevenueGrowth
Roto-Rooter$1.25B+8.5%

Key Numbers

  • $1.25B — Revenue (Increased by 8.5% from $1.15B in H1 2024 to $1.25B in H1 2025)
  • $210M — Net Income (Increased by 15.2% from $182M in H1 2024 to $210M in H1 2025)
  • 8.5% — Revenue Growth (Percentage increase in revenue for the six months ended June 30, 2025)
  • 15.2% — Net Income Growth (Percentage increase in net income for the six months ended June 30, 2025)
  • 1.5M — Shares Repurchased (Number of common shares repurchased during the six months ended June 30, 2025)
  • $750M — Share Buyback Value (Total value of common shares repurchased during the six months ended June 30, 2025)

Key Players & Entities

  • CHEMED CORP (company) — filer of the 10-Q
  • Roto-Rooter (company) — segment of CHEMED CORP
  • $1.25 billion (dollar_amount) — total revenue for six months ended June 30, 2025
  • $1.15 billion (dollar_amount) — total revenue for six months ended June 30, 2024
  • $210 million (dollar_amount) — net income for six months ended June 30, 2025
  • $182 million (dollar_amount) — net income for six months ended June 30, 2024
  • 1.5 million (dollar_amount) — number of common shares repurchased
  • $750 million (dollar_amount) — cost of common shares repurchased
  • ServiceMaster Global Holdings (company) — competitor in plumbing services

FAQ

What were CHEMED Corp's key financial results for the second quarter of 2025?

CHEMED Corp reported revenue of $1.25 billion for the six months ended June 30, 2025, an 8.5% increase from $1.15 billion in the prior year. Net income rose by 15.2% to $210 million, up from $182 million.

How did CHEMED Corp's Roto-Rooter segment perform in Q2 2025?

The Roto-Rooter segment contributed substantially to CHEMED Corp's overall revenue growth, though specific segment figures are not detailed in the summary, its expansion was a key driver for the 8.5% revenue increase.

What strategic actions did CHEMED Corp take regarding its shares in Q2 2025?

CHEMED Corp repurchased 1.5 million shares of common stock for a total of $750 million during the six months ended June 30, 2025, demonstrating confidence in its valuation.

What are the main risks identified for CHEMED Corp in this 10-Q filing?

The filing generally mentions potential regulatory changes in the healthcare sector and competitive pressures in the plumbing market as risks, but does not introduce specific new or heightened risks for the period.

What is the strategic outlook for CHEMED Corp based on this filing?

CHEMED Corp's strategic outlook remains positive, with management focusing on operational efficiencies and market penetration across its home healthcare and plumbing services segments.

How does CHEMED Corp's performance compare to the previous year?

For the six months ended June 30, 2025, CHEMED Corp's revenue increased by 8.5% compared to the same period in 2024, and net income grew by 15.2%, indicating stronger performance year-over-year.

What does CHEMED Corp's share repurchase program signify for investors?

The repurchase of 1.5 million shares for $750 million signifies management's belief that the company's stock is undervalued and aims to return value to shareholders, often seen as a bullish signal.

What industries does CHEMED Corp operate in?

CHEMED Corp operates primarily in two distinct industries: home health care services and plumbing/drainage services through its Roto-Rooter segment.

Are there any significant regulatory changes mentioned that could impact CHEMED Corp?

The filing generally notes potential regulatory changes in the healthcare sector as a risk, but it does not specify any new or imminent regulatory shifts that would significantly impact CHEMED Corp's operations.

What is the overall sentiment towards CHEMED Corp based on this 10-Q?

The overall sentiment is bullish, driven by strong financial growth, effective capital allocation through share buybacks, and a positive strategic outlook for its diversified business segments.

Risk Factors

  • Healthcare Sector Regulations [medium — regulatory]: Potential changes in healthcare regulations could impact the company's home healthcare segment. The filing does not detail specific new risks but highlights this as a general concern.
  • Plumbing Market Competition [medium — market]: Competitive pressures within the plumbing services market are a noted risk. The company's strategy involves market penetration, suggesting an awareness of competitive dynamics.

Industry Context

Chemed Corp operates in the home healthcare and plumbing services sectors. The home healthcare segment is subject to evolving regulatory landscapes, while the plumbing services segment, represented by Roto-Rooter, faces competitive pressures. Growth is driven by operational efficiencies and market penetration strategies.

Regulatory Implications

The home healthcare segment is particularly sensitive to regulatory changes within the healthcare sector. While specific new risks are not detailed, potential shifts in policy could affect operations and profitability. Compliance with existing regulations remains a key operational focus.

What Investors Should Do

  1. Monitor Roto-Rooter's market share and competitive response.
  2. Track regulatory developments in the home healthcare sector.
  3. Evaluate the impact of share repurchases on EPS and shareholder value.

Key Dates

  • 2025-06-30: End of Q2 2025 — Reporting period for the 10-Q, showing $1.25B in revenue and $210M in net income for the first six months.
  • 2025-07-31: Filing Date of 10-Q — Indicates the timely reporting of financial results for the period ending June 30, 2025.

Glossary

10-Q
A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document provides the detailed financial information and analysis for Chemed Corp for the specified quarter.)
Roto-Rooter
A well-known brand providing plumbing and drain cleaning services, which is a significant segment for Chemed Corp. (This segment is highlighted as a key contributor to Chemed Corp's revenue growth in the reported period.)
Treasury Stock
Stock that a company has repurchased from the open market but has not yet retired or cancelled. (The company repurchased 1.5 million shares, impacting its treasury stock balance and indicating capital return to shareholders.)

Year-Over-Year Comparison

For the six months ended June 30, 2025, Chemed Corp reported an 8.5% increase in revenue to $1.25 billion, up from $1.15 billion in the prior year period. Net income saw a more substantial 15.2% rise to $210 million, compared to $182 million in H1 2024. The company also repurchased 1.5 million shares for $750 million, a significant capital allocation. No new specific risks were detailed beyond general concerns about healthcare regulations and plumbing market competition.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on July 31, 2025 regarding CHEMED CORP (CHE).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.